Polycystic ovary syndrome and gynecological cancers: Is there a link?

References

• Solomon CG. The epidemiology of polycystic ovary syn-drome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am 1999;28:247–263.
   Google Scholar
• Lobo RA, Carmina E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 2000;132:989–993.
   PubMed Web of Science ®Google Scholar
• Asuncion M, Calvo RM, San Milian JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434–2438.
   Google Scholar
• Slowey MJ. Polycystic ovary syndrome: new perspective on an old problem. South Med J 2001;94:190–196.
   PubMed Web of Science ®Google Scholar
• Balen A, Rajkowha M. Polycystic ovary syndrome - a systemic disorder? Best Pract Res Clin Obstet Gynaecol 2003;17:263–274.
   PubMedGoogle Scholar
• Guzick DS. Polycystic ovary syndrome. Obstet Gynecol 2004;103:181–193.
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19: 41–47.
   Google Scholar
• Silfen ME, Denburg MR, Manibo AM, et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 2003;88:4682–4688.
   PubMed Web of Science ®Google Scholar
• Salehi M, Bravo-Vera R, Sheikh A, Gouller A, Poretsky L. Pathogenesis of polycystic ovary syndrome: what is the role of obesity? Metabolism 2004;53:358–376.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, Sancho J, San Millan JL. Serum interleukin-18 concentra-tions are increased in the polycystic ovary syndrome: Relationship to insulin resistance and to obesity. J Clin Endocrinol Metab 2004;89:806–811.
   PubMed Web of Science ®Google Scholar
• Prat J. Endometrial cancer: Epidemiology, pathology, and natural history. In: Genazzani AR, editor. Hormone replace-ment therapy and cancer. The current status of research and practice. New York: Parthenon Publishing; 2002. pp 105–114.
   Google Scholar
• Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P. Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann NY Acad Sci 2001;943:296–315.
   PubMed Web of Science ®Google Scholar
• Nagamani M, Stuart CA, Dunhardt PA, Doherty PA. Specific binding sites for insulin and insulin-like growth factor I in human endometrial cancer. Am J Obstet Gynecol 1991;165:1865–1871.
   Google Scholar
• Giudice LC, Dsupin BA, Irwin JC. Steroid and peptide regulation of insulin-like growth factor-binding proteins secreted by human endometrial stromal cells is dependent on stromal differentiation J Clin Endocrinol Metab 1992;75: 1235–1241.
   Google Scholar
• Rutanen EM, Nyman T, Lehtovirta P, Ammala M, Pekonen F. Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors. Int J Cancer 1994;59: 307–312.
   Google Scholar
• Rutanen EM. Insulin-like growth factors in endometrial function. Gynecol Endocrinol 1998;12:399–406.
   PubMed Web of Science ®Google Scholar
• Gadducci A, Genazzani AR. Steroid hormones in endome-trial and breast cancer. Review. Eur J Gynaecol Oncol 1997;18:371–378.
   PubMed Web of Science ®Google Scholar
• Rutanen EM. Endocrine, paracrine and intracrine mechan-isms of growth regulation in normal and malignant endometrial epithelium. In: Genazzani AR, editor. Hormone replacement therapy and cancer. The current status of research and practice. New York: Parthenon Publishing; 2002. pp 115–124.
   Google Scholar
• Kaaks R. Plasma insulin, IGF-1 and breast cancer. Gynecol Obstet Fertil 2001;29:185–191.
   Google Scholar
• Randolph JF Jr, Kipersztok S, Ayers JW, Ansbacher R, Peegel H, Menon KM. The effect of insulin on aromatase activity in isolated human endometrial glands and stroma. Am J Obstet Gynecol 1987;157:1534–1539.
   Google Scholar
• Lukanova A, Zeleniuch-Jacquotte A, Lundin E, et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP-1, -2 and -3 and risk of endometrial cancer. Int J Cancer 2004; 108:262–268.
   PubMed Web of Science ®Google Scholar
• Levi F, La Vecchia C, Negri E, Parazzini F, Franceschi S. Body mass at different ages and subsequent endometrial cancer risk. hit J Cancer 1992;50:567–571.
   PubMed Web of Science ®Google Scholar
• Zelmanowicz A, Hildesheim A, Sherman ME, et al. Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. Gynecol Oncol 1998;69:253–257.
   PubMedGoogle Scholar
• Hu FB. Overweight and obesity in women: health risks and consequences. J Worn Health 2003;12:163–172.
   Google Scholar
• Potischman N, Hoover RN, Brinton LA, et al. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996;88:1127–1135.
   PubMed Web of Science ®Google Scholar
• Speert H. Carcinoma of the endometrium in young women. Surg Gynaecol Obstet 1949;88:332–336.
   Google Scholar
• Dockerty MB, Jackson RL. The Stein-Leventhal syndrome: analysis of 43 cases with special reference to association with endometrial carcinoma. Am J Obstet Gynecol 1957;73:161–173.
   PubMed Web of Science ®Google Scholar
• Jafari K, Javaheri G, Ruiz G. Endometrial adenocarcinoma and the Stein-Leventhal syndrome. Obstet Gynecol 1978;51:97–100.
   Google Scholar
• Dennefors BL, Knutson F, Janson PO, jansson I, Hamberger L. Ovarian steroid production in a woman with polycystic ovary syndrome associated with endometrial cancer. Acta Obstet Gynecol Scand 1985;64:387–392.
   Google Scholar
• Farhi DC, Nosanchuk J, Silverberg SG. Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol 1986;68: 741–745.
   Google Scholar
• Smyczek-Gargya B, Geppert M. Endometrial cancer asso-ciated with polycystic ovaries in young women. Pathol Res Pract 1992;188:946–948.
   Google Scholar
• Chadli-Debbiche A, Dellenbach P, Philippe E, Hummel M. Endometrioid adenocarcinoma of the uterine isthmus asso-ciated with atypical endometrial hyperplasia and polycystic ovaries. Apropos of a case with bicornuate uterus in a 38 year old woman. Arch Anat Cytol Pathol 1993;41: 171–174.
   Google Scholar
• Goluda M, Andrzejewski L. A rare case of concurrent endometrial carcinoma and PCO syndrome. Ginekol Pol 1995;66:484–485.
   Google Scholar
• Gregorini SD, Lespi PJ, Alvarez GR. Endometrial carcinoma with polycystic ovaries. Report of two cases in women younger than 40 years old. Medicina (B Aires) 1997;57: 209–212.
   Google Scholar
• Salha O, Martin-Hirsch P, Lane G, Sharma V. Endometrial carcinoma in a young patient with polycystic ovarian syndrome: First suspected at time of embryo transfer. Hum Reprod 1997;12:959–962.
   PubMed Web of Science ®Google Scholar
• Kurabayashi T, Kase H, Suzuki M, Sugaya S, Fujita K, Tanaka K. Endometrial abnormalities in infertile women. J Reprod Med 2003;48:455–459.
   Google Scholar
• Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003;361: 1810–1812.
   Google Scholar
• Rarnzy I, Nisker JA. Histologic study of ovaries from young women with endometrial adenocarcinoma. Am J Chin Pathol 1979;71:253–256.
   Google Scholar
• Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403–407.
   Google Scholar
• Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984;64:417–420.
   PubMed Web of Science ®Google Scholar
• Escobedo LG, Lee NC, Peterson HB, Wingo PA. Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol 1991;77:124–128.
   PubMed Web of Science ®Google Scholar
• Ho SP, Tan KT, Pang MW, Ho TH. Endometrial hyperplasia and the risk of endometrial carcinoma. Singapore Med J 1997;38:11–15.
   Google Scholar
• Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil 2000;3:101–105.
   PubMedGoogle Scholar
• Niwa K, Imai A, Hashimoto M, et al. A case-control study of uterine endometrial cancer of pre- and post-menopausal women. Oncol Rep 2000;7:89–93.
   PubMed Web of Science ®Google Scholar
• Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal mem-branes, and decidua. J Chin Endocrinol Metab 1990;70: 421–430.
   PubMed Web of Science ®Google Scholar
• Lincoln SR, Lei ZM, Rao CV, Yussman MA. The expression of human chorionic gonadotropin/human lutei-nizing hormone receptors in ectopic human endometrial implants. J Chin Endocrinol Metab 1992;75:1140–1144.
   PubMedGoogle Scholar
• Lei ZM, Reshef E, Rao V. The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels. J Chin Endocrinol Metab 1992;75:651–659.
   Google Scholar
• Lin J, Lei ZM, Lojun S, Rao CV, Satyaswaroop PG, Day TG. Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas. J Clin Endocrinol Metab 1994;79:1483–1491.
   PubMedGoogle Scholar
• Konishi I, Koshiyama M, Mandai M, et al. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women. Gynecol Oncol 1997; 65:273–280.
   PubMedGoogle Scholar
• Druckmann R, Rohr UD. IGF-1 in gynaecology and obstetrics: Update 2002. Maturitas 2002;41 (Suppl 1):565–S83.
   Google Scholar
• Bokhman JV, Chepick OF, Volkova AT, Vishnevsky AS. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol Oncol 1985;20:139–155.
   PubMed Web of Science ®Google Scholar
• Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endo-metrium in women under age 40. Obstet Gynecol 1997;90:434–440.
   PubMed Web of Science ®Google Scholar
• Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 1997;79:320–327.
   Google Scholar
• Kung FT, Chen WJ, Chou HH, Ko SF, Chang SY. Conservative management of early endometrial adenocarci-noma with repeat curettage and hormone therapy under assistance of hysteroscopy and laparoscopy. Hum Reprod 1997;12:1649–1653.
   Google Scholar
• Vinker S, Shani A, Open M, Fenig E, Dgani R. Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate? Eur J Obstet Gynecol Reprod Biol 1999;83:63–65.
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Gadducci A. Chemoprevention and endo-crine therapy of endometrial carcinoma. In: Genazzani AR, editor. Hormone replacement therapy and cancer. The current status of research and practice. New York: Parthenon Publishing; 2002. pp 125–134.
   Google Scholar
• Yarali H, Bozdag G, Aksu T, Ayhan A. A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively. Fertil Steril 2004;81:214–216.
   PubMed Web of Science ®Google Scholar
• Salazar OM, Bonfiglio TA, Patten SF, et al. Uterine sarcomas: natural history, treatment and prognosis. Cancer 1978;42:1152–1160.
   PubMedGoogle Scholar
• Olah KS, Dunn JA, Gee H. Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma. Br J Obstet Gynaecol 1992;99: 590–594.
   Google Scholar
• Gadducci A, Sartori E, Landoni F, et al. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases. Eur J Gyaecol Oncol 2002;23:295–299.
   PubMed Web of Science ®Google Scholar
• Piver MS, Rutledge FN, Copeland L, Webster K, Blumen-son L, Suh O. Uterine endolymphatic stromal myosis: a collaborative study. Obstet Gynecol 1984;64:173–178.
   Google Scholar
• Gadducci A, Sartori E, Landoni F, et al. Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996;63:247–253.
   PubMed Web of Science ®Google Scholar
• Schwartz PE, Chu MC, Zheng W, Mor G. Endometrial stromal tumors - are they hormonally sensitive? In: Genaz-zani AR, editor. Hormone replacement therapy and cancer. The current status of research and practice. New York: Parthenon Publishing; 2002. pp 148–154.
   Google Scholar
• Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL Jr. Treatment of endometrial stromal tumors. Gynecol Oncol 1990;36:60–65.
   Google Scholar
• Reich O, Regauer S, Urdl W, Lahousen M, Winter R. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 2000;82: 1030–1034.
   Google Scholar
• Ansink AC, Cross PA, Scorer P, de Barros Lopes A, Monaghan JM. The hormonal receptor status of uterine carcinosarcomas (mixed mullerian tumours): an immuno-histochemical study. J Chin Pathol 1997;50:328–331.
   Google Scholar
• Chumas JC, Mann WJ, Tseng L. Malignant mixed Mullerian tumor of the endometrium in a young woman with polycystic ovaries. Cancer 1983;52:1478–1481.
   Google Scholar
• Press MF, Scully RE. Endometrial 'sarcomas' complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy. Gynecol Oncol 1985;21:135–154.
   Google Scholar
• Altaras MM, Jaffe R, Cohen I, Gruber A, Yanai-Inbar I, Bernheim J. Role of prolonged excessive estrogen stimulation in the pathogenesis of endometrial sarcomas: two cases and a review of the literature. Gynecol Oncol 1990;38:273–277.
   Google Scholar
• Ali S, Wells M. Mixed Mullerian tumors of the uterine corpus: a review. hit J Gynecol Cancer 1993;3:1–11.
   PubMed Web of Science ®Google Scholar
• Karabakhtsian R, Heller DS, Singhal P, Sama J. Malignant mixed mesodermal tumor in a young woman with polycystic ovary syndrome. A case report. J Reprod Med 2002;47:946–948.
   Google Scholar
• Sartori E, Bazzurini L, Gadducci A, et al. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol 1987;67:70–75.
   Google Scholar
• Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 1997;67:1005–1012.
   PubMed Web of Science ®Google Scholar
• Gnagy S, Ming EE, Devesa SS, Hartge P, Whittemore AS. Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use. Epidemiology 2000;11: 102–105.
   Google Scholar
• Chiaffarino F, Pelucchi C, Parazzini F, et al. Reproductive and hormonal factors and ovarian cancer. Ann Oncol 2001; 12:337–341.
   PubMed Web of Science ®Google Scholar
• Riman T, Dickman PW, Nilsson S, et al. Risk factors for invasive epithelial ovarian cancer: Results from a Swedish case-control study. Am J Epidemiol 2002;156:363–373.
   PubMed Web of Science ®Google Scholar
• Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epide-miol 1992;136: 1184–1203.
   Google Scholar
• Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771–776.
   Google Scholar
• Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999;354:1586–1590.
   Google Scholar
• Doyle P, Maconochie N, Beral V, Swerdlow AJ, Tan SL. Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 2002;17:2209–2213.
   Google Scholar
• Ness RB, Cramer DW, Goodman MT, et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002;155:217–224.
   PubMed Web of Science ®Google Scholar
• Kashyap S, Moher D, Fung MF, Rosenwaks Z. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis. Obstet. Gynecol 2004;103:785–794.
   PubMed Web of Science ®Google Scholar
• Cardillo MR, Petrangeli E, Aliotta N, et al. Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study. J Exp Chin Cancer Res 1998;17:231–237.
   PubMed Web of Science ®Google Scholar
• Lau KM, Mok SC, Ho SM. Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and andro-gen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci USA 1999;96:5722–5727.
   Google Scholar
• Lu jj, Zheng Y, Kang X, et al. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer. Gynecol Oncol 2000;79:158–168.
   Google Scholar
• Parrott JA, Doraiswamy V, Kim G, Mosher R, Skinner MK. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Mol Cell Endocrinol 2001;172:213–222.
   Google Scholar
• Syed V, Ulinski G, Mok SC, Yiu GK, Ho SM. Expression of gonadotropin receptor and growth responses to key repro-ductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res 2001;61:6768–6776.
   Google Scholar
• Li AJ, Baldwin RL,, Karlan BY. Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures. Am J Obstet Gynecol 2003;189:22–27.
   Google Scholar
• Modugno F. Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: A HuGE review. Am J Epidemiol 2004;159:319–335.
   PubMed Web of Science ®Google Scholar
• Stewart SL, Querec TD, Gruver BN, O'Hare B, Babb JS, Patriotis C. Gonadotropin and steroid hormones stimulate proliferation of the rat ovarian surface epithelium. J Cell Physiol 2004;198:119–224.
   Google Scholar
• Choi KC, Kang SK, Tai CJ, Auersperg N, Leung PC. Estradiol up-regulates antiapoptotic Bc1-2 messenger ribo-nucleic acid and protein in tumorigenic ovarian surface epithelium cells. Endocrinology 2001;142: 2351–2360.
   Google Scholar
• Rodriguez GC, Walmer DK, Cline M, et al. Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J Soc Gynecol Invest 1998;5: 271–276.
   PubMedGoogle Scholar
• Rodriguez GC, Nagarsheth NP, Lee KL, et al. Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta. J Natl Cancer Inst 2002;94:50–60.
   PubMed Web of Science ®Google Scholar
• Syed V, Ho SM. Progesterone-induced apoptosis in im-mortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL. Oncogene 2003;22:6883–6890.
   PubMed Web of Science ®Google Scholar
• Helzlsouer KJ, Alberg AJ, Gordon GB, et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. J Am Med Assoc 1995;274:1926–1930.
   PubMed Web of Science ®Google Scholar
• Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774–1786.
   PubMed Web of Science ®Google Scholar
• Wang PH, Chang C. Androgens and ovarian cancers. Eur J Gynaecol Oncol 2004;25:157–163.
   PubMed Web of Science ®Google Scholar
• Silva EG, Tornos C, Fritsche HA, et al. The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Mod Pathol 1997;10:879–883.
   PubMed Web of Science ®Google Scholar
• Evangelou A, Jindal SK, Brown TJ, Letarte M. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells. Cancer Res 2000;60:929–935.
   PubMed Web of Science ®Google Scholar
• Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994;30A:344–350.
   PubMed Web of Science ®Google Scholar
• Purdie D, Green A, Bain C, et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer 1995;62:678–684.
   Google Scholar
• Farrow DC, Weiss NS, Lyon JL, Daling JR. Association of obesity and ovarian cancer in a case-control study. Am J Epidemiol 1989;129:1300–1304.
   Google Scholar
• Engeland A, Tretli S, Bjorge T. Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 2003;95: 1244–1248.
   Google Scholar
• Kuper H, Cramer DW, Titus-Ernstoff L. Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes Control 2002;13:455–463.
   Google Scholar
• Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y; Canadian Cancer Registries Epidemiology Research Group. Association of obesity and cancer risk in Canada. Am J Epidemiol 2004;159:259–268.
   PubMed Web of Science ®Google Scholar
• Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE. Obesity, weight gain, and ovarian cancer. Obstet Gynecol 2002;100:288–296.
   PubMed Web of Science ®Google Scholar
• Anderson JP, Ross JA, Folsom AR. Anthropometric vari-ables, physical activity, and incidence of ovarian cancer: The Iowa Women's Health Study. Cancer 2004;100:1515–1521.
   Google Scholar
• Parazzini F, Moroni S, La Vecchia C, Negri E, dal Pino D, Bolis G. Ovarian cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 1997;33:1634–1637.
   Google Scholar
• Lukanova A, Toniolo P, Lundin E, et al. Body mass index in relation to ovarian cancer: a multi-centre nested case-control study. Int J Cancer 2002;99:603–608.
   PubMed Web of Science ®Google Scholar
• Resta L, Russo S, Colucci GA, Prat J. Morphologic precursors of ovarian epithelial tumors. Obstet Gynecol 1993;82:181–186.
   PubMedGoogle Scholar
• Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996;88:554–559.
   PubMed Web of Science ®Google Scholar
• Powolny M, Pietrzak P, Borucki W. A case of coexistence of polycystic ovary syndrome and ovarian carcinoma. Ginekol Pol 1999;70:298–301.
   Google Scholar
• Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update 2001;7:522–525.
   PubMed Web of Science ®Google Scholar
• Atiomo WU, El-Mahdi E, Hardiman P. Familial associations in women with polycystic ovary syndrome. Fertil Steril 2003;80:143–145.
   PubMed Web of Science ®Google Scholar
• Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Chin Oncol 1988;24:29–43.
   PubMedGoogle Scholar
• Ross RK. Breast cancer: epidemiology, pathology, and natural history. In: Genazzani AR, editor. Hormone replacement therapy and cancer. The current status of research and practice. New York: Parthenon Publishing; 2002. pp 31–37.
   Google Scholar
• Helewa M, Levesque P, Provencher D, Lea RH, Rosolowich V, Shapiro HM; Breast Disease Committee and Executive Committeee and Council, Society of Obstetricians and Gynaecologists of Canada. Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can 2002;24:164–180.
   Google Scholar
• Yong LC, Brown CC, Schatzkin A, Schairer C. Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989. Am J Epidemiol 1996;143:985–995.
   Google Scholar
• Ziegler RG, Hoover RN, Nomura AM, et al. Relative weight, weight change, height, and breast cancer risk in Asian-American women. J Natl Cancer Inst 1996;88:650–660.
   PubMed Web of Science ®Google Scholar
• Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001;91:421–430.
   PubMed Web of Science ®Google Scholar
• Wasserman L, Flat SW, Natarajan L, et al. Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors. Int J Obes Relat Metab Disord 2004;28:49–56.
   Google Scholar
• Carmichael AR, Bates T. Obesity and breast cancer: a review of the literature.Breast 2004;13:85–92.
   PubMed Web of Science ®Google Scholar
• Ursin G, Longnecker MP, Haile RW, Greenland S. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 1995;6:137–141.
   PubMed Web of Science ®Google Scholar
• Secreto G, Zumoff B. Abnormal production of androgens in women with breast cancer. Anticancer Res 1994;14:2113–2117.
   PubMed Web of Science ®Google Scholar
• Kaaks R. Nutrition, hormones, and breast cancer: Is insulin the missing link? Cancer Causes Control 1996;7:605–625.
   PubMed Web of Science ®Google Scholar
• Gharani N, Waterworth DM, Batty S, et al. Association of the steroid synthesis gene CYP1 la with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 1997;6: 397–402.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Bartzis MI, Bergiele AT, Tsianateli TC, Kouli CR. Microsatellite polymorphism (tttta)(n) at - 528 base pairs of gene CYP1 lax influences hyperandro-genemia in patients with polycystic ovary syndrome. Fertil Steril 2000;73: 735–741.
   Google Scholar
• Franks S, Gharani N, McCarthy M. Candidate genes in polycystic ovary syndrome. Hum Reprod Update 2001;7: 405–410.
   PubMed Web of Science ®Google Scholar
• Daneshmand S, Weitsman SR, Navab A, Jakimiuk AJ, Magoffin DA. Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with poly-morphisms in the cholesterol side-chain cleavage and 17a-hydroxylase/C(17-20) lyase promoters. Fertil Steril 2002; 77:274–280.
   Google Scholar
• Zheng W, Gao YT, Shu XO, et al. Population-based case-control study of CYP11A gene polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prey 2004;13: 709–714.
   Google Scholar
• Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer.Am J Epidemiol 1991;134:818–824.
   PubMed Web of Science ®Google Scholar
• Anderson KE, Sellers TA, Chen PL, Rich SS, Hong CP, Folsom AR. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer 1997;79:494–499.
   PubMed Web of Science ®Google Scholar
• Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Chin Epidemiol 1998;51:581–586.
   Google Scholar